Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 3 NETWORK 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Serotonin Syndrome 1 Neuroendocrine Tumors 1 Biliary Tract Neoplasms 1

Interventions

telotristat ethyl 1 pasireotide 1 lanreotide 1 Receptor-Like Protein Tyrosine Phosphatases, Class 2 1 Random Allocation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Serotonin Syndrome × telotristat ethyl × Clear all

NCT03223428 2024-07-24

RELAX

TerSera Therapeutics LLC

223 enrolled 16 charts

Neuroendocrine Tumors, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡